| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.12 | 0.007 |